About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00561184

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

To assess persistence of antibody titers 17-18 months after primary immunization with two 0.5mL intramuscular (IM) doses of H5N1 influenza vaccine containing H5N1 influenza antigen, as measured by Hem...

Lead sponsor: Novartis Vaccines•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Novartis Vaccines

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy subjects who previously participated in study V87P1, but did not receive the booster dose on day 202

Exclusion Criteria

•Pregnant or breastfeeding
•Receipt of another vaccine or any investigational agent within the past 4 weeks
•Surgery planned during the study period

Related studies

RECRUITINGPhase 3

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

NCT07240558 · Influenza (Pandemic), Avian Influenza, and more

COMPLETEDPhase 3

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

NCT02839330 · Avian Influenza

COMPLETEDPhase 2

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

NCT03682120 · Avian Influenza, Influenza Immunisation

COMPLETEDPhase 2

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

NCT03318315 · Avian Influenza, Influenza, and more

COMPLETEDPhase 2

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

NCT02213354 · Avian Influenza

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 1, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment47

Start dateOct 2007

Last updatedDec 1, 2016

Condition

Avian Influenza

Locations shown

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini

Chieti

01: Dipartimento di Scienze della Salute, Sezione Igiene e Medicina Preventiva, Università di Genova

Genova

03: Ufficio di Igiene e Sanità Pubblica di Lanciano, ASL Lanciano -Vasto, Via Spaventa, 37,

Lanciano

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 1, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions